Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Ovarian Neoplasms 2Breast Neoplasms 2Prostatic Neoplasms 1Pancreatic Neoplasms 1Lung Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Oxaliplatin 17Leucovorin 13Fluorouracil 13Cetuximab 12Bevacizumab 10pembrolizumab 7Specimen Handling 7Nivolumab 7Magnetic Resonance Spectroscopy 6Irinotecan 6Capecitabine 6encorafenib 4Pemetrexed 4Gemcitabine 4Cisplatin 4fludarabine 3cemiplimab 3Laparoscopy 3Folfox protocol 3Early Intervention, Educational 3Cyclophosphamide 3Celecoxib 3Carboplatin 3Biopsy 3trifluridine tipiracil drug combination 2relatlimab 2pertuzumab 2palbociclib 2durvalumab 2dehydroftorafur 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colonic Neoplasms × Genetic Profile × 90 days × Clear all
NCT07555639 2026-04-29

GERSOM

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase NA Active not recruiting
4,000 enrolled
BreastGastrointestinalGynecologic

Breast Neoplasms, Colonic Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡